Detalles de la búsqueda
1.
Patients' preference of trastuzumab administration (subcutaneous versus intravenous) in HER2-positive metastatic breast cancer: Results of the randomised MetaspHer study.
Eur J Cancer;
82: 230-236, 2017 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-28648618
2.
Highly favorable outcome in BRCA-mutated metastatic breast cancer patients receiving high-dose chemotherapy and autologous hematopoietic stem cell transplantation.
Bone Marrow Transplant;
52(3): 498, 2017 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-28092355
3.
Highly favorable outcome in BRCA-mutated metastatic breast cancer patients receiving high-dose chemotherapy and autologous hematopoietic stem cell transplantation.
Bone Marrow Transplant;
51(8): 1082-6, 2016 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-27042835
4.
Immunohistochemical subtypes predict the clinical outcome in high-risk node-negative breast cancer patients treated with adjuvant FEC regimen: results of a single-center retrospective study.
BMC Cancer;
15: 697, 2015 Oct 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-26466893
5.
Long-term survival of advanced triple-negative breast cancers with a dose-intense cyclophosphamide/anthracycline neoadjuvant regimen.
Br J Cancer;
110(6): 1413-9, 2014 Mar 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-24569467
6.
Breast cancer patients' views on the use of genomic testing to guide decisions about their postoperative chemotherapy.
Public Health Genomics;
16(3): 110-7, 2013.
Artículo
en Inglés
| MEDLINE | ID: mdl-23571814
7.
Tailored chemotherapy based on tumour gene expression analysis: breast cancer patients' misinterpretations and positive attitudes.
Eur J Cancer Care (Engl);
21(2): 242-50, 2012 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-22070677
8.
Sentinel lymphadenectomy for the staging of clinical axillary node-negative breast cancer before neoadjuvant chemotherapy.
Eur J Surg Oncol;
35(9): 916-20, 2009 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-19157769
9.
A phase II trial to evaluate gefitinib as second- or third-line treatment in patients with recurring locoregionally advanced or metastatic cervical cancer.
Gynecol Oncol;
108(1): 42-6, 2008 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-17980406
10.
A phase II study of a paclitaxel and oxaliplatin combination in platinum-sensitive recurrent advanced ovarian cancer patients.
Ann Oncol;
17(3): 429-36, 2006 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-16500913
11.
Post-operative sequential high-dose chemotherapy with haematopoietic stem cell support as front-line treatment in advanced ovarian cancer: a phase II multicentre study.
Bone Marrow Transplant;
37(7): 651-9, 2006 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-16501596
12.
High-dose sequential epirubicin and cyclophosphamide with peripheral blood stem cell support for advanced breast cancer: results of a phase II study.
Br J Cancer;
85(9): 1240-6, 2001 Nov 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-11720455
13.
Primary chemotherapy for operable breast cancer: incidence and prognostic significance of ipsilateral breast tumor recurrence after breast-conserving surgery.
J Clin Oncol;
19(18): 3828-35, 2001 Sep 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-11559720
14.
Response to chemotherapy is a major parameter-influencing long-term survival of metastatic breast cancer patients.
Ann Oncol;
12(2): 231-7, 2001 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-11300330
15.
Residual tumor cell contamination in peripheral blood stem cells collections of 117 breast cancer patients evaluated by immunocytochemical technique.
J Hematother Stem Cell Res;
10(6): 855-62, 2001 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-11798511
16.
[How to finance chemotherapy with new cancer drugs? / Comment financer l'utilisation de nouveaux médicaments de chimiothérapie?
Bull Cancer;
87(10): 745-54, 2000 Oct.
Artículo
en Francés
| MEDLINE | ID: mdl-11084538
17.
Predictive factors of response to first-line chemotherapy in 1426 women with metastatic breast cancer.
Eur J Cancer;
36(18): 2301-12, 2000 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-11094303
18.
Prognostic value of persistent node involvement after neoadjuvant chemotherapy in patients with operable breast cancer.
Br J Cancer;
83(11): 1480-7, 2000 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-11076657
19.
Detection of MUC1-expressing mammary carcinoma cells in the peripheral blood of breast cancer patients by real-time polymerase chain reaction.
Clin Cancer Res;
6(8): 3117-22, 2000 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-10955792
20.
[Retrospective multivariate analysis of radio-pathological correlations of nonpalpable breast lesions. Experience of the Hospital Saint-Louis]. / Analyse rétrospective multivariée de la corrélation radio-anatomopathologique de lésions infracliniques du sein. Expérience de l'hôpital Saint-Louis.
Rev Med Interne;
21(4): 337-43, 2000 Apr.
Artículo
en Francés
| MEDLINE | ID: mdl-10795326